Eli Lilly (LLY) Goodwill & Intangibles (2009 - 2026)

Eli Lilly (LLY) reported Goodwill & Intangibles of $13.5 billion for Q1 2026, up 14.61% on a YoY basis from $11.8 billion in Q1 2025, and up 8.74% quarter-over-quarter from $12.4 billion in Q4 2025.

Eli Lilly (LLY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Eli Lilly has reported Goodwill & Intangibles for 18 years, with the latest figure at $13.5 billion in Q1 2026.

  • For the quarter ending Q1 2026, Goodwill & Intangibles rose 14.61% year-over-year to $13.5 billion; the trailing twelve-month figure through Mar 2026 stood at $13.5 billion (up 14.61% YoY), and the FY2025 full-year result was $12.4 billion, up 4.05% from the prior year.
  • Goodwill & Intangibles for Q1 2026 stood at $13.5 billion, up from $12.4 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $13.5 billion in Q1 2026, with the low at $10.9 billion in Q3 2023.
  • Historically, Goodwill & Intangibles has averaged $11.8 billion across 5 years, with a median of $11.7 billion in 2024.
  • Annual changes were most pronounced in 2022 — Goodwill & Intangibles slipped 6.42% — and 2026, when it climbed 14.61%.
  • Eli Lilly's Goodwill & Intangibles stood at $11.3 billion in 2022, then grew by 5.02% to $11.8 billion in 2023, then grew by 0.76% to $11.9 billion in 2024, then gained by 4.05% to $12.4 billion in 2025, then increased by 8.74% to $13.5 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $13.5 billion (Q1 2026), $12.4 billion (Q4 2025), and $12.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 13.50 Bn
Dec 31, 2025 12.42 Bn
Sep 30, 2025 12.34 Bn
Jun 30, 2025 11.68 Bn
Mar 31, 2025 11.78 Bn
Dec 31, 2024 11.94 Bn
Sep 30, 2024 12.31 Bn
Jun 30, 2024 12.40 Bn
Mar 31, 2024 11.70 Bn
Dec 31, 2023 11.85 Bn
Sep 30, 2023 10.87 Bn
Jun 30, 2023 10.98 Bn
Mar 31, 2023 11.16 Bn
Dec 31, 2022 11.28 Bn
Sep 30, 2022 11.02 Bn
Jun 30, 2022 11.39 Bn
Mar 31, 2022 11.37 Bn
Dec 31, 2021 11.58 Bn
Sep 30, 2021 11.77 Bn
Jun 30, 2021 11.87 Bn